West Family Memorial Fund, Inagene and Timeposters Fellowship and industry funding for speaker/consultation/research fees from iGan, Boehringer Ingelheim, Abbvie, Braxia Health (Canadian Rapid Treatment Centre of Excellence), Braxia Scientific, Janssen, Allergan, Lundbeck, Sunovion and COMPASS
Not only did patients change what they ate, but they visited far fewer restaurants and ate less while going out
GHK-Cu does not meaningfully suppress appetite or drive fat loss
The compound reaches peak blood levels within 1-3 hours of sublingual administration, which means the strongest appetite control kicks in right around lunchtime, precisely when food decisions tend to get difficult for most people managing their diet on GLP-1 medications